CCS and SweetSpot are joining forces to improve remote care for patients with diabetes.
CCS, a St. Petersburg, Florida-based home medical equipment provider focusing on diabetes treatment, said in a Feb. 10 announcement that its collaboration with SweetSpot — a remote diabetes management company in St. Louis— is “a new pilot program across select U.S. markets designed to expand access to remote care, improve clinical outcomes, and support providers with scalable, preventive diabetes care solutions.”
The pilot “will leverage SweetSpot’s continuous data insights and virtual clinical support team, which operates as an extension of the provider, alongside CCS’s established chronic care ecosystem,” CCS added. “By integrating SweetSpot’s monitoring tools and team of certified diabetes care and education specialists (CDCESs) directly into existing clinical workflows, the partnership aims to enhance both the patient and provider experience.”
In the announcement, CCS noted that more than 40 million people in the United States are living with diagnosed or undiagnosed diabetes, referencing a January 2026 Centers for Disease Control report. More than a quarter of those people — 27.6%, an estimated 11 million — are undiagnosed.
The pilot program, scheduled to launch early this year, will focus on endocrinology clinics, with Sweet Spot providing “continuous glucose data review, personalized feedback, and virtual diabetes education between appointments, helping clinicians stay connected to patients.”
Collaborating with SweetSpot will enable CCS to “offer providers a more holistic way to monitor patients remotely, identify issues earlier, and support adherence between visits,” the announcement said.
“Diabetes care doesn’t stop when patients leave the clinic, but most practices lack the tools and bandwidth to proactively monitor who needs help and take action between in-office visits,” said Tony Vahedian, the CEO of CCS. “By combining our trusted provider relationships and SweetSpot’s ability to support clinics in extending their capacity for remote care, we can help more people manage their diabetes in real time — without adding burden to clinicians.”
“SweetSpot empowers providers to give patients better care and continuous support in a scalable way,” said CEO Stephen Von Rump. “Partnering with CCS allows us to deliver even greater impact and address one of the biggest gaps in chronic disease management: what happens between appointments.”
